PubMed=22499954; DOI=10.1093/intimm/dxs053
Tsukamoto H., Fukudome K., Takao S., Tsuneyoshi N., Ihara H., Ikeda Y., Kimoto M.
Multiple potential regulatory sites of TLR4 activation induced by LPS as revealed by novel inhibitory human TLR4 mAbs.
Int. Immunol. 24:495-506(2012)

PubMed=26602081; DOI=10.1016/j.febslet.2015.11.018
Tsukamoto H., Ukai I., Yamagata Y., Takeuchi S., Kubota K., Kozakai S., Suzuki N., Kimoto M., Tomioka Y.
Leucine-rich repeat 2 of human Toll-like receptor 4 contains the binding site for inhibitory monoclonal antibodies.
FEBS Lett. 589:3893-3898(2015)

PubMed=28741733; DOI=10.1002/1873-3468.12768
Tsukamoto H., Yamagata Y., Ukai I., Takeuchi S., Okubo M., Kobayashi Y., Kozakai S., Kubota K., Numasaki M., Kanemitsu Y., Matsumoto Y., Tomioka Y.
An inhibitory epitope of human Toll-like receptor 4 resides on leucine-rich repeat 13 and is recognized by a monoclonal antibody.
FEBS Lett. 591:2406-2416(2017)